WV HB4721 | 2026 | Regular Session

Status

Sponsorship: Partisan Bill (Republican 2)
Status: Introduced on January 22 2026 - 25% progression
Action: 2026-01-22 - To House Health and Human Resources
Pending: House Health & Human Resources Committee
Text: Latest bill text (Introduced) [HTML]

Summary

The purpose of this bill is to add a provision in Schedule I drugs relating to the scheduling of crystalline polymorph psilocybin, if approved by the Food and Drug Administration and the Drug Enforcement Administration, and declare that will be lawful to prescribe, distribute and market this drug.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Relating to drugs and adding a provision relating to the scheduling of crystalline polymorph psilocybin approved by the Food and Drug Administration

Sponsors


History

DateChamberAction
2026-01-22HouseTo House Health and Human Resources
2026-01-22HouseIntroduced in House
2026-01-22HouseTo Health and Human Resources then Judiciary
2026-01-22HouseFiled for introduction

Same As/Similar To

HB4640 (Similar To) 2026-02-02 - On 1st reading, House Calendar

Subjects


Code Citations

ChapterArticleSectionCitation TypeStatute Text
60A2204Amended CodeCitation Text

West Virginia State Sources


feedback